The mRNA levels of NRF2 and GPX4 in the CHD group were increased (P < 0.05) (Figures 7(a) and 7(b)), while the protein expression of NRF2 and GPX4 was decreased (P < 0.05) (Figures 7(c) and 7(d)). This evidence concerns the gene NFE2L2 and coronary artery disorder.